Theodosia Androutsopoulou

Ms. Theodosia Androutsopoulou

Department of Biology, University of Patras, Rio, Greece
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2024 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
Georgios KalampouniasGeorgios Kalampounias
Georgios Kalampounias
CGChrysavgi Gardeli
Chrysavgi Gardeli
SASPYRIDON ALEXIS
SPYRIDON ALEXIS
EAElena Anagnostopoulou
Elena Anagnostopoulou
TATheodosia Androutsopoulou
Theodosia Androutsopoulou
Panagiotis KatsorisPanagiotis Katsoris
Panagiotis Katsoris
Cunninghamella elegans NRRL-1393 is an oleaginous fungus able to synthesize and accumulate unsaturated fatty acids, amongst which the bioactive gamma-linolenic acid (GLA) has potential anti-cancer activities. C. elegans was cultured in shake-flask nitrogen-limited media with either glycerol or glucose (both at ≈60 g/L) employed as the sole substrate. The assimilation rate of both substrates was similar, as the total biomass production reached 13.0–13.5 g/L, c. 350 h after inoculation (for both instances, c. 27–29 g/L of substrate were consumed). Lipid production was slightly higher on glycerol-based media, compared to the growth on glucose (≈8.4 g/L vs. ≈7.0 g/L). Lipids from C. elegans grown on glycerol, containing c. 9.5% w/w of GLA, were transformed into fatty acid lithium salts (FALS), and their effects were assessed on both human normal and cancerous cell lines. The FALS exhibited cytotoxic effects within a 48 h interval with an IC50 of about 60 μg/mL. Additionally, a suppression of migration was shown, as a significant elevation of oxidative stress levels, and the induction of cell death. Elementary differences between normal and cancer cells were not shown, indicating a generic mode of action; however, oxidative stress level augmentation may increase susceptibility to anticancer drugs, improving chemotherapy effectiveness.

14 August 2025 in Cells
Verified
Journal Article
Open access
PDF file
Georgios KalampouniasGeorgios Kalampounias
Georgios Kalampounias
TATheodosia Androutsopoulou
Theodosia Androutsopoulou
Panagiotis KatsorisPanagiotis Katsoris
Panagiotis Katsoris
ELK1 is a Transcription factor (TF) belonging to the ETS-domain TF family, mainly activated via RAS-RAF-MEK-ERK signaling. As a nethermost pathway molecule, ELK1 binds to Serum-response elements (SREs) and directly regulates the transcription of Immediate early genes (IEGs) including FOS and EGR1. Due to ELK1’s influence on key cellular processes such as proliferation, migration, apoptosis evasion, and Epithelial-to-mesenchymal transition (EMT), its role as a key contributor to tumorigenesis is emerging. In recent years, elevated expression and/or activation of ELK1 has been reported in various malignancies, including lung, breast, prostate, colorectal, blood, gastric, liver, cervical, thyroid and ovarian cancer. ELK1 acts primarily through direct DNA binding but also through interaction with other oncogenes, noncoding RNA molecules, TFs, and upstream kinases (other than ERK1/2), thus participating in diverse axes of transcriptional regulation. Its crucial role in IEG expression has been particularly implicated in cancer progression, metastasis, and drug resistance. Owing to its role in multiple cellular functions and its subsequent oncogenic potential, further elucidation of intracellular ELK1 interactions is of paramount importance. This review aims to summarize current evidence on ELK1’s involvement in solid tumors, dissect reported mechanistic roles, and highlight recent insights that could fuel future ventures of high translational interest.

12 November 2024 in Fermentation
Verified
Journal Article
Open access
PDF file
Georgios KalampouniasGeorgios Kalampounias
Georgios Kalampounias
PDPanagiotis Dritsas
Panagiotis Dritsas
Dimitris KarayannisDimitris Karayannis
Dimitris Karayannis
TATheodosia Androutsopoulou
Theodosia Androutsopoulou
CGChrysavgi Gardeli
Chrysavgi Gardeli
Panagiotis KatsorisPanagiotis Katsoris
Panagiotis Katsoris
Thamnidium elegans and Mortierella alpina are two oleaginous fungi that belong to Mucoromycota that synthesize polyunsaturated fatty acids, which are credited with multiple health benefits and possible anticancer properties. These fungi were cultivated on culture media, with glucose or glycerol as a carbon source. After extracting the lipids, we transformed them into fatty acid lithium salts (FALSs), which are water-soluble and absorbable mammalian cells, including DU-145 and PC-3 cancer cells. The two cell lines, both long-established prostate cancer models, were treated with FALSs and indicated increased susceptibility to the lipid derivatives. The viability and proliferation rates were significantly reduced, as well as their migratory capabilities, which were significantly impaired compared to olive oil-derived FALS, which was used as a control substance. We conclude that the FALS derivatives of microbial lipids from these organisms exhibit anticancer effects, by suppressing the proliferation and migration of human prostate cancer cell lines.

Verified
Journal Article
Open access
PDF file
Georgios KalampouniasGeorgios Kalampounias
Georgios Kalampounias
KZKalliopi Zafeiropoulou
Kalliopi Zafeiropoulou
TATheodosia Androutsopoulou
Theodosia Androutsopoulou
SASPYRIDON ALEXIS
SPYRIDON ALEXIS
Argiris SymeonidisArgiris Symeonidis
Argiris Symeonidis
Panagiotis KatsorisPanagiotis Katsoris
Panagiotis Katsoris
The rapid emergence of resistance limits the application of proteasome inhibitors against solid tumors, despite their effectiveness in the treatment of hematological malignancies. Resistant phenotypes are complex and multifaceted, and, thus, the mechanisms involved have not been adequately described. In this study, a Bortezomib-resistant prostate cancer cell line is created by using the PC-3 cell as a prostate carcinoma model of high metastatic potential. The main biochemical differences and adaptations exhibited by the resistant cells revolve around apoptosis evasion, autophagy induction (functioning as a ubiquitin-proteasome system substitute), expression of epithelial-to-mesenchymal transition markers, and increased aggressiveness. Broad-spectrum signaling pathway analyses also reveal an upregulation and activation of Nf-κB, STAT3, cJun, and Elk1 transcription factors in the resistant cells. Additionally, intracellular reactive oxygen species assays reveal a downregulation in resistant cells, which is theorized to be a consequence of metabolic changes, increased autophagic flux, and antioxidative enzyme action. These findings expand our understanding of proteasome inhibitor resistance and highlight key kinases and transcription factors as novel potential therapeutic targets. Effective inhibition of resistance-specific pathways could re-sensitize the cells to proteasome inhibitors, thus surpassing current therapeutic limitations.

2 December 2023 in Cureus
Verified
Journal Article
Open access
PDF file
KZKalliopi Zafeiropoulou
Kalliopi Zafeiropoulou
Georgios KalampouniasGeorgios Kalampounias
Georgios Kalampounias
SASpyridon Alexis
Spyridon Alexis
TATheodosia Androutsopoulou
Theodosia Androutsopoulou
PKPanagiotis Katsoris
Panagiotis Katsoris
Argiris SymeonidisArgiris Symeonidis
Argiris Symeonidis
Myelodysplastic syndromes (MDS) constitute a heterogeneous group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis and an elevated risk of transformation to acute myeloid leukemia (AML). Available disease-modifying treatment approaches are limited. The ineffectiveness of proteasome inhibitors (PIs) in MDS patients is currently investigated, although it is unclear whether they rapidly develop resistance to PIs or whether proteasome proteolytic activity (PPA) is constitutively lower in the hematopoietic cells of these patients, thus limiting treatment effectiveness. We investigated 20 patients with MDS, categorized according to the International Prognostic Scoring System (IPSS) into a lower- or a higher-risk group. Peripheral blood mononuclear cells, bone marrow mononuclear cells, and cluster of differentiation 34-positive (CD34+) cells were isolated and assessed for the chymotrypsin-like activity of the proteasome and β5 subunit accumulation. Additionally, intracellular reactive oxygen species (ROS) generation was screened. The lower-risk patient group (n=10) exhibited significantly lower proteasome activity (p<0.001) compared to both the higher-risk group (n=10) and healthy subjects (n=10). Furthermore, the lower-risk group had elevated oxidative stress levels (p<0.0001) and reduced β5 subunit expression (p=0.0286). Both parameters were shown to be associated with transfusion dependency, since transfusion-dependent patients (n=5 in each subgroup) had decreased proteasome activity and simultaneously exhibited higher ROS levels. Our results indicate that reduced β5 expression might potentially explain PIs' ineffectiveness in lower-risk MDS, elucidating the importance of the risk group in the selection of the proper treatment algorithm.

6 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
Georgios KalampouniasGeorgios Kalampounias
Georgios Kalampounias
PDPanagiotis Dritsas
Panagiotis Dritsas
Dimitris KarayannisDimitris Karayannis
Dimitris Karayannis
TATheodosia Androutsopoulou
Theodosia Androutsopoulou
CGChrysavgi Gardeli
Chrysavgi Gardeli
Panagiotis KatsorisPanagiotis Katsoris
Panagiotis Katsoris
Thamnidium elegans and Mortierella alpina are two oleaginous fungi that belong to Mucoromycota that synthesize polyunsaturated fatty acids which are credited with multiple health benefits and possible anticancer properties. These fungi were cultivated on culture media with glucose or glycerol as a carbon source. After extracting the lipids, we transformed them into fatty acid lithium salts (FALS), which are water-soluble and absorbable mammalian cells, including DU-145 and PC-3 cancer cells. The two cell lines, both long-established prostate cancer models, were treated with FALS and indicated increased susceptibility to the lipid derivatives. The viability and proliferation rates were significantly reduced, as well as their migratory capabilities, which were significantly impaired compared to olive-oil-derived FALS, which were used as a control substance. We conclude that the FALS derivatives of microbial lipids from these organisms exhibit anticancer effects by suppressing the proliferation and migration of human prostate cancer cell lines.